Abstract
Selective activation of aliphatic C–H bonds in polycyclic terpenoids offers a potent strategy for exploring diverse chemical space in drug design, yet challenges persist in achieving site- and diastereoselectivity, especially with increasing structural complexity. Here we report a bioinformatics-driven terpene–P450 discovery strategy to develop bacterial cytochrome P450s for selective activation of aliphatic C–H bonds in structurally intricate pentacyclic triterpenoids (PTs). The identified ApPT demonstrated elegant diastereoselectivity and broad substrate tolerance, facilitating a chemo-enzymatic platform to explore the chemical space of PTs at previously inaccessible sites. Protein crystallization and computational analysis reveal the mechanism of the preliminary C–H bond activation selectivity of ApPT towards various PTs, particularly an example of enzymatic C7-to-C15 relay oxidation mediated by 1,5-hydrogen atom transfer. This work offers ApPT as a valuable biocatalyst to explore the chemical space of PTs via aliphatic C–H bond activation, demonstrating the advantage of our biocatalyst-discovery strategy for the late-stage diversification of polycyclic terpenoids.

This is a preview of subscription content, access via your institution
Access options
Access Nature and 54 other Nature Portfolio journals
Get Nature+, our best-value online-access subscription
$32.99 / 30 days
cancel any time
Subscribe to this journal
Receive 12 print issues and online access
$259.00 per year
only $21.58 per issue
Buy this article
- Purchase on SpringerLink
- Instant access to the full article PDF.
USD 39.95
Prices may be subject to local taxes which are calculated during checkout





Similar content being viewed by others
Data availability
The authors declare that all data supporting the findings of this study are available in the main text or Supplementary Information. The X-ray crystal structures of 1b, 3a and 10a are available free from the Cambridge Crystallographic Data Centre under reference numbers: CCDC 2290949 (1b), 2290950 (3a) and 2290948 (10a). The atomic coordinates of ApPT have been deposited in the Protein Data Bank under accession code 8W7G. Source data are provided with this paper.
References
Nes, W. D. Biosynthesis of cholesterol and other sterols. Chem. Rev. 111, 6423–6451 (2011).
White, N. J. Qinghaosu (artemisinin): the price of success. Science 320, 330–334 (2008).
Zhang, X. et al. Divergent synthesis of complex diterpenes through a hybrid oxidative approach. Science 369, 799–806 (2020).
Xu, H. et al. Celastrol suppresses colorectal cancer via covalent targeting peroxiredoxin 1. Signal Transduct. Target. Ther. 8, 51 (2023).
Hong, B. K., Luo, T. P. & Lei, X. G. Late-stage diversification of natural products. ACS Cent. Sci. 6, 622–635 (2020).
Hartwig, J. F. & Larsen, M. A. Undirected, homogeneous C–H bond functionalization: challenges and opportunities. ACS Cent. Sci. 2, 281–292 (2016).
White, M. C. & Zhao, J. Aliphatic C–H oxidations for late-stage functionalization. J. Am. Chem. Soc. 140, 13988–14009 (2018).
Bakanas, I., Lusi, R. F., Wiesler, S., Hayward Cooke, J. & Sarpong, R. Strategic application of C–H oxidation in natural product total synthesis. Nat. Rev. Chem. 7, 783–799 (2023).
Mondal, D., Snodgrass, H. M., Gomez, C. A. & Lewis, J. C. Non-native site-selective enzyme catalysis. Chem. Rev. 123, 1038–10431 (2023).
Docherty, J. H. et al. Transition-metal-catalyzed C–H bond activation for the formation of C–C bonds in complex molecules. Chem. Rev. 123, 7692–7760 (2023).
Sheng, H. & Sun, H. Synthesis, biology and clinical significance of pentacyclic triterpenes: a multi-target approach to prevention and treatment of metabolic and vascular diseases. Nat. Prod. Rep. 28, 543–593 (2011).
Liby, K. T., Yore, M. M. & Sporn, M. B. Triterpenoids and rexinoids as multifunctional agents for the prevention and treatment of cancer. Nat. Rev. Cancer 7, 357–369 (2007).
Li, H., Sun, J., Xiao, S., Zhang, L. & Zhou, D. Triterpenoid-mediated inhibition of virus–host interaction: is now the time for discovering viral entry/release inhibitors from nature? J. Med. Chem. 63, 15371–15388 (2020).
Mullard, A. FDA approves first Friedreich’s ataxia drug. Nat. Rev. Drug Discov. 22, 258 (2023).
Zhou, S., Zhang, Z.-J. & Yu, J.-Q. Copper-catalysed dehydrogenation or lactonization of C(sp3)–H bonds. Nature 629, 363–369 (2024).
Michaudel, Q. et al. Improving physical properties via C–H oxidation: chemical and enzymatic approaches. Angew. Chem. Int. Ed. 53, 12091–12096 (2014).
Karimov, R. R. & Hartwig, J. F. Transition-metal-catalyzed selective functionalization of C(sp3)–H bonds in natural products. Angew. Chem. Int. Ed. 57, 4234–4241 (2018).
Berger, M., Knittl-Frank, C., Bauer, S., Winter, G. & Maulide, N. Application of relay C–H oxidation logic to polyhydroxylated oleanane triterpenoids. Chem 6, 1183–1189 (2020).
Simmons, E. M. & Hartwig, J. F. Catalytic functionalization of unactivated primary C–H bonds directed by an alcohol. Nature 483, 70–73 (2012).
Mu, T., Wei, B., Zhu, D. & Yu, B. Site-selective C–H hydroxylation of pentacyclic triterpenoids directed by transient chiral pyridine-imino groups. Nat. Commun. 11, 4371 (2020).
Urlacher, V. B. & Girhard, M. Cytochrome P450 monooxygenases in biotechnology and synthetic biology. Trends Biotechnol. 37, 882–897 (2019).
Rudolf, J. D., Chang, C. Y., Ma, M. & Shen, B. Cytochromes P450 for natural product biosynthesis in Streptomyces: sequence, structure, and function. Nat. Prod. Rep. 34, 1141–1172 (2017).
Li, Y. et al. Natural products of pentacyclic triterpenoids: from discovery to heterologous biosynthesis. Nat. Prod. Rep. 40, 1303–1353 (2023).
Moses, T. et al. Combinatorial biosynthesis of sapogenins and saponins in Saccharomyces cerevisiae using a C-16α hydroxylase from Bupleurum falcatum. Proc. Natl Acad. Sci. USA 111, 1634–1639 (2014).
Malhotra, K. & Franke, J. Cytochrome P450 monooxygenase-mediated tailoring of triterpenoids and steroids in plants. Beilstein J. Org. Chem. 18, 1289–1310 (2022).
Durairaj, P. & Li, S. Functional expression and regulation of eukaryotic cytochrome P450 enzymes in surrogate microbial cell factories. Eng. Microbiol. 2, 100011 (2022).
Li, A. et al. Regio- and stereoselective steroid hydroxylation at C7 by cytochrome P450 monooxygenase mutants. Angew. Chem. Int. Ed. 59, 12499–12505 (2020).
Acevedo-Rocha, C. G. et al. P450-catalyzed regio- and diastereoselective steroid hydroxylation: efficient directed evolution enabled by mutability landscaping. ACS Catal. 8, 3395–3410 (2018).
Shen, P. et al. Microbial transformation of glycyrrhetinic acid derivatives by Bacillus subtilis ATCC 6633 and Bacillus megaterium CGMCC 1.1741. Bioorg. Med. Chem. 28, 115465 (2020).
Rein, J. et al. Generality-oriented optimization of enantioselectiveaminoxyl radical catalysis. Science 380, 706–712 (2023).
Ciaramella, A., Minerdi, D. & Gilardi, G. Catalytically self-sufficient cytochromes P450 for green production of fine chemicals. Rendiconti Lincei 28, 169–181 (2016).
McLachlan, M. J., Johannes, T. W. & Zhao, H. Further improvement of phosphite dehydrogenase thermostability by saturation mutagenesis. Biotechnol. Bioeng. 99, 268–274 (2008).
Agematu, H. et al. Hydroxylation of testosterone by bacterial cytochromes P450 using the Escherichia coli expression system. Biosci. Biotechnol. Biochem. 70, 307–311 (2006).
Austin, M. B., O’Maille, P. E. & Noel, J. P. Evolving biosynthetic tangos negotiate mechanistic landscapes. Nat. Chem. Biol. 4, 217–222 (2008).
Helfrich, E. J. N., Lin, G. M., Voigt, C. A. & Clardy, J. Bacterial terpene biosynthesis: challenges and opportunities for pathway engineering. Beilstein J. Org. Chem. 15, 2889–2906 (2019).
Wang, Z. et al. Cytochrome P450 mediated cyclization in eunicellane derived diterpenoid biosynthesis. Angew. Chem. Int. Ed. 62, e202312490 (2023).
Liu, W. et al. Discovery of P450-modified sesquiterpenoids levinoids A–D through global genome mining. J. Nat. Prod. 87, 879–883 (2024).
Oberg, N., Zallot, R. & Gerlt, J. A. EFI-EST, EFI-GNT, and EFI-CGFP: Enzyme Function Initiative (EFI) web resource for genomic enzymology tools. J. Mol. Biol. 435, 168018 (2023).
Park, S. et al. Expedient synthesis of alphitolic acid and its naturally occurring 2-O-ester derivatives. J. Nat. Prod. 82, 895–902 (2019).
Hashimoto, T., Hirose, D. & Taniguchi, T. Direct synthesis of 1,4-diols from alkenes by iron-catalyzed aerobic hydration and C–H hydroxylation. Angew. Chem. Int. Ed. 53, 2730–2734 (2014).
Kiely-Collins, H., Winter, G. E. & Bernardes, G. J. L. The role of reversible and irreversible covalent chemistry in targeted protein degradation. Cell Chem. Biol. 28, 952–968 (2021).
Sporn, M. B. et al. New synthetic triterpenoids: potent agents for prevention and treatment of tissue injury caused by inflammatory and oxidative stress. J. Nat. Prod. 74, 537–545 (2011).
Cojocaru, V., Winn, P. J. & Wade, R. C. The ins and outs of cytochrome P450s. Biochim. Biophys. Acta 1770, 390–401 (2007).
Holm, L. & Sander, C. Protein structure comparison by alignment of distance matrices. J. Mol. Biol. 233, 123–138 (1993).
Chai, L. et al. Biotransformation mechanism of pesticides by cytochrome P450: a DFT study on dieldrin. Chem. Res. Toxicol. 33, 1442–1448 (2020).
Acknowledgements
We appreciate financial support from the National Key Research and Development Program of China (grant no. 2022YFA1503200 to Y.L.), the National Science Foundation of China (grant nos 82473823 to L.-B.D., 22525301 to Y.L. and 22403046 to H.C.), the Project Program of State Key Laboratory of Natural Medicines at China Pharmaceutical University (grant no. SKLNMZZ2024JS44 to L.-B.D.), the Natural Science Foundation of Jiangsu Province (grant nos BK20240097 to L.-B.D., BK20230018 to Y.L. and BK20241231 to H.C.), the Fundamental Research Funds for the Central Universities (grant no. 2632025TD06 to L.-B.D.), the Jiangsu Provincial Major Science and Technology Special Project (grant no. BG2024046 to L.-B.D.) and Postgraduate Research & Practice Innovation Program of Jiangsu Province (grant no. KYCX25_1064 to X.Z.). We thank the staff at beamlines BL02U1, BL10U2 and BL18U1 of Shanghai Synchrotron Radiation Facility for assistance during data collection. We thank the High Performance Computing Center (HPCC) of Nanjing University for doing the numerical calculations in this paper on its blade cluster system. We thank D. Nelson from University of Tennessee for assigning the name CYP161H12 in accordance with the standard Cytochrome P450 Nomenclature. We also express our gratitude to C. Luo from Shanghai Institute of Materia Medica, Chinese Academy of Sciences, Y. Zheng from China Pharmaceutical University, H. Li from Peking University and F. Li from Fudan University for valuable discussions.
Author information
Authors and Affiliations
Contributions
L.-B.D. and Y.L. conceived the project. X.Z., H.C., Y.L. and L.-B.D. designed the experiments. X.Z., Y.W., Z.W., X.L., F.-R.L., X.P. and H.-M.X. performed the experiments. H.C., S.X., J.Q. and Y.L. carried out the computational study. All authors analysed and discussed the results. X.Z., H.C., Y.L. and L.-B.D. wrote the paper with inputs from all co-authors.
Corresponding authors
Ethics declarations
Competing interests
The authors declare no competing interests.
Peer review
Peer review information
Nature Chemistry thanks Charles-Alexandre Mattelaer, Andreas Schneider and the other, anonymous, reviewer(s) for their contribution to the peer review of this work.
Additional information
Publisher’s note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Extended data
Extended Data Fig. 1 Strategies for aliphatic C–H activation of pentacyclic terpenoids (PTs): organic synthesis versus biocatalysis in this work.
The detailed efforts for these strategies are summarized in Supplementary Fig. 1.
Extended Data Fig. 2 Twenty-nine putative terpenoid-producing biosynthetic gene clusters (BGCs) from 11 bacterial strains.
The blue arrows show anchors of putative terpene synthases (TSs) for EFI-GNT. The red arrows show associated CYP450s in the clusters. All terpene synthases in the genome are considered suitable for guiding the discovery of CYP450s, without being restricted to a particular type.
Extended Data Fig. 3 Optimization of the in vitro reaction conditions for ApPT-catalyzed oxidation of 1.
a, Reaction parameters optimization including alternative redox partners (RPs), biocatalyst loads, as well as the pH. Yields were determined by HPLC analysis. Conditions: 2 mM 1 in 5% (v/v) DMSO, 1 mM NADP+, 100 mM Na2HPO3, opt13, and ApPT/RPs in 100 mM kpi buffer at 23 °C, 220 rpm for 20 h. aBiocatalyst loads in entries 1–6 can be effectively determined according to the Supplementary Methods. Due to the biocatalysts in entries 7–10 cannot be purified, the hydroxylated activity was determined using the same amount of crude enzyme lysate with OD600 = 30. b, Different types and expression modes of RPs with ApPT. RP1 and RP2 represent self-sufficient ApPT chimeras that were expressed in the pET28a(+) plasmid. RP3, RP4, and RP5 represent RPs that were individually expressed alongside ApPT in the pRSFDuet-1 plasmid.
Extended Data Fig. 4 In vitro anti-tumor and anti-inflammatory activities of glycyrrhetinic acid derivatives (GADs).
a, Anti-inflammatory activities of the selected GADs in LPS-induced RAW264.7 cells. L-NMMA (NG-monomethyl-L-arginine) was used as a positive control. b, Anti-proliferation activities of the selected GADs against five cancer cell lines. Bardoxolone methyl (CDDO-Me) was used as a positive control. c, Selective inhibitory effects on tumor cell (HeLa) and non-tumor cell (Ect1/E6E7) for representative compounds-25, 26, 27, and CDDO-Me (48 h; n = 3 biologically replicated experiments; mean ± s.d.). HepG2, human liver cancer cell line. SW480, human colorectal adenocarcinoma cell line. A549, human non-small cell lung cancer cell line. PC-3, human prostate cancer cell line. HeLa, human cervical cancer cell line. Ect1/E6E7, human cervical immortalized squamous cell line. N.D., not detected. RAW264.7, mouse mononuclear macrophage cell line. SF (selectivity factor), the ratio of IC50Ect1/E6E7 to IC50HeLa.
Extended Data Fig. 5 DFT calculations and MD simulations for the C7 hydroxylation of 1.
a, Gibbs free energy profiles and DFT-optimized transition states for 1. b, The binding free energies ΔGbind between ApPT and 1-TSC15, 1, and 1-TSC7, respectively. Computed at the PCM (chlorobenzene)-B3LYP-D3/6-311 + G(d,p)+SDD(Fe)//PCM (chlorobenzene)-B3LYP-D3/6-31 G(d)+LanL2DZ(Fe) level of theory. Distances are shown in Å.
Supplementary information
Supplementary Information (download PDF )
Supplementary Figs. 1–27, Tables 1–24 and Notes 1–5.
Supplementary Data 1 (download PDF )
DFT-computed Gibbs free energies and Cartesian coordinates.
Supplementary Data 2 (download XLSX )
Numerical data underlying Supplementary Figs. 9, 10 and 17b.
Source data
Source Data Fig. 5 (download XLSX )
Numerical data underlying Fig. 5c.
Rights and permissions
Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.
About this article
Cite this article
Zhang, X., Chen, H., Wang, Y. et al. Exploring bacterial cytochrome P450s for selective activation of aliphatic C–H bonds in pentacyclic triterpenoids. Nat. Chem. (2026). https://doi.org/10.1038/s41557-026-02106-9
Received:
Accepted:
Published:
Version of record:
DOI: https://doi.org/10.1038/s41557-026-02106-9


